www.oncotarget.com Oncotarget, 2019, Vol. 10, (No. 3), pp: 259-262 Research Perspective Gestational tumors as a model to probe reticulate evolution in human neoplasia Yuri Lazebnik1 1 Lerna Consulting, New Haven, CT, USA Correspondence to: Yuri Lazebnik, email:
[email protected] Keywords: cancer; reticulate evolution; gestational tumors; cell fusion; horizontal gene transfer Received: December 11, 2018 Accepted: December 12, 2018 Published: January 08, 2019 Copyright: Lazebnik. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT Reticulate evolution, which involves the transfer of genes and other inheritable information between organisms, is of interest to a cancer researcher if only because “pirating” a trait can help a cell and its progeny adapt, survive, or take over much faster than by accumulating random mutations. However, despite being observed repeatedly in experimental models of neoplasia, reticulate evolution is assumed to be negligible in human cancer primarily because detecting gene transfer between the cells of the same genetic background can be difficult or impossible. This commentary suggests that gestational tumors, which are genetically distinct from the women who carry them, provide an opportunity to test whether reticulate evolution affects the development of human neoplasia. The evolutionary model of cancer views neoplastic be acquired within a generation, which for unicellular cells as unicellular asexual organisms that evolve by organisms and cells means days, if not hours. accumulating genetic and epigenetic alterations [1-5].